Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2023-08-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the supervisory board meeting resolutions of Zhejiang Tailin Biotechnology Co., Ltd. It includes the approval of the 2023 semi-annual report and a special report on the use of raised funds. The document states that the full semi-annual report and the special report are published on the official disclosure website, indicating this document is a summary announcement rather than the full report itself. The document length is short (1175 characters) and it mainly reports the meeting decisions and references the full reports elsewhere. Therefore, it fits the category of Regulatory Filings (RNS) as it is a regulatory announcement about meeting resolutions and report approvals, not the full interim report or financial statements themselves.
2023-08-29 Chinese
关于第三届董事会第十六次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion related to the 16th meeting of the third board of directors of Zhejiang Tailin Biotechnology Co., Ltd. It discusses specific matters such as the use of raised funds in the first half of 2023, absence of related party fund occupation, and external guarantees. The document references regulatory guidelines and provides an independent opinion rather than full financial statements or comprehensive reports. The length is short (866 characters), and it is a formal opinion on specific board meeting matters, not a full annual or interim report. This fits best under Board/Management Information (MANG), which covers announcements related to board or senior management matters.
2023-08-29 Chinese
2023年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "浙江泰林生物技术股份有限公司2023 年半年度报告全文" which translates to "Zhejiang Tailin Bioengineering Co., Ltd. 2023 Semi-Annual Report Full Text." It explicitly states it is a half-year report covering the period from January to June 2023. The content includes detailed financial data, management discussion and analysis, company business description, financial indicators, and other comprehensive information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. There is no indication that this is an announcement of a report or a certification document. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-29 Chinese
关于2023年半年度报告披露的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (318 characters) indicating that the company's 2023 semi-annual report has been disclosed on an official website. It does not contain the actual semi-annual report or financial data but merely informs investors where to find the report. According to the 'MENU VS MEAL' rule, such a brief notice about report disclosure is classified as a Report Publication Announcement (RPA).
2023-08-29 Chinese
关于取得专利证书及商标注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of patent certificates and trademark registration certificates. It details the number and types of patents and trademarks obtained by the company and its subsidiaries, emphasizing the impact on intellectual property protection and brand recognition. There is no financial data, no mention of financial results, no regulatory certifications, or meeting-related materials. The document is an announcement of intellectual property achievements, which does not fit into financial reports, management reports, or regulatory filings categories. It is a general corporate announcement about patents and trademarks, which is best classified under Regulatory Filings (RNS) as a fallback category for miscellaneous corporate announcements that do not fit other specific categories.
2023-08-22 Chinese
关于变更注册资本并完成工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding a change in registered capital and completion of industrial and commercial registration changes. It includes details about the change in registered capital amount and updated business license information. The document references board meetings and shareholder meetings where the capital change was approved, but it does not contain financial statements or detailed financial performance data. The document is relatively short (1228 characters) and serves as an official announcement of a capital change and registration update, not a full financial report or detailed management discussion. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2023-08-04 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.